CXCR4 and breast cancer: It was previously shown that treatment of MDA-MB-231 breast cancer cells with DHA reduced surface expression of CXCR4, one of the chemokine receptors crucial for chemoattraction of metastatic cells, but also significantly reduced CXCR4-mediated cell migration.